LQDA: Liquidia Corporation Stock

by  •  • Comments Off on LQDA: Liquidia Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,439.85
Enterprise Value ($M) 1,410.90
Book Value ($M) 49.71
Book Value / Share 0.58
Price / Book 28.96
NCAV ($M) -0.51
NCAV / Share -0.01
Price / NCAV -2,817.70

Profitability (mra)
Return on Invested Capital (ROIC) -0.70
Return on Assets (ROA) -0.70
Return on Equity (ROE) -1.61

Liquidity (mrq)
Quick Ratio 2.91
Current Ratio 2.93

Balance Sheet (mrq) ($M)
Current Assets 177.21
Assets 227.43
Liabilities 177.72
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 14.00
Operating Income -121.29
Net Income -130.39

Cash Flow Statement (mra) ($M)
Cash From Operations -93.42
Cash from Investing -8.44
Cash from Financing 194.66

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Legend Aggregator, LP 2.20 -74.10
11-12 13G/A Manning Paul B 7.90 5.54
11-08 13G BlackRock, Inc. 5.00 0.00
09-12 13D/A Caligan Partners LP 9.80 16.06

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-02 1,288,750 4,314,993 29.87
2025-05-30 385,695 1,165,389 33.10
2025-05-29 584,795 1,639,787 35.66
2025-05-28 638,297 2,152,046 29.66

(click for more detail)

Similar Companies
LIXT – Lixte Biotechnology Holdings, Inc. LPCN – Lipocine Inc.
LPTX – Leap Therapeutics, Inc. LSTA – Lisata Therapeutics, Inc.
LTRN – Lantern Pharma Inc.


Financial data and stock pages provided by
Fintel.io